RVRC Holding AB (publ) (0GE)
Market Closed
7 Aug, 20:00
XMUN 
€
5. 63
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 5.63
Previous Close Want to track 0GE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
0GE closed Friday higher at €5.63, an increase of 0% from Thursday's close, completing a monthly increase of 9.6397% or €0.5. Over the past 12 months, 0GE stock lost -8.6039%.
0GE is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on CBOE (SEK).
0GE Chart
RVRC Holding AB (publ) (0GE) FAQ
What is the stock price today?
The current price is €5.63.
On which exchange is it traded?
RVRC Holding AB (publ) is listed on XMUN.
What is its stock symbol?
The ticker symbol is 0GE.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has RVRC Holding AB (publ) ever had a stock split?
No, there has never been a stock split.
RVRC Holding AB (publ) Profile
| Textiles, Apparel & Luxury Goods Industry | Consumer Discretionary Sector | Rene Faber CEO | XMUN Exchange | - ISIN |
| FR Country | 9,961 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Sartorius Stedim Biotech S.A. is a cornerstone in the biopharmaceutical industry, providing a vast array of instruments and consumables used globally. The company's extensive product portfolio caters to the needs of medication manufacturers, food industries, chemical sectors, as well as research and development laboratories. Founded in 1870, with its headquarters in Aubagne, France, it stands as a subsidiary of Sartorius AG. Its offerings facilitate numerous critical processes in the biopharmaceutical production and development chain, from cell cultivation to the transportation of biological products.
Products and Services
- Cell Lines & Cell Culture Media: These foundational components are essential for the cultivation and maintenance of cells in the laboratory, enabling the growth of precise and replicable biological products.
- Bioreactors: Sartorius Stedim Biotech S.A. provides cutting-edge bioreactors that are integral for the cell cultivation process, facilitating the development of vaccines, enzymes, and other biotherapeutic agents.
- Separation, Purification, and Concentration Products: A comprehensive range of products designed for the critical stages of biopharmaceutical manufacturing, ensuring the purity and potency of the final products.
- Storage and Transportation Systems: Solutions for the safe handling, storage, and transportation of intermediate and finished biological products, addressing the challenges of maintaining product integrity.
- Service Offerings: The company extends its expertise through services in cell cultivation, fermentation, separation, purification, and fluid management, further supporting the biopharmaceutical production cycle.
- Batch and Intensified Chromatography Systems: These systems are tailored for smaller molecules, like oligonucleotides, peptides, and insulin, optimizing purification processes for efficiency and effectiveness.
- Recombinant Albumin-Based Solutions: Offering a safe and animal-free alternative for cell culture growth mediums, enhancing the productivity and reliability of biopharmaceutical products.
- Data Analytics Software: Advanced software solutions for modeling and optimizing the processes of biopharmaceutical development and production, empowering companies with data-driven insights for process improvement.
Contact Information
Address: Zone Industrielle Les Paluds
Phone: 33 4 42 84 56 00
Website: https://www.sartorius.com
